Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab InjectionsUnusual Whales·Aug 9 at 07:48 PM02493-0.72%688062-1.50%
Mabwell passes Brazil ANVISA GMP inspection for denosumab biosimilarsPUBT·Aug 9 at 07:00 PM02493-0.72%688062-1.50%
Mabwell Wins NMPA Nod to Test Novel Autoimmune Antibody 9MW5211 in VitiligoTip Ranks·Jul 15 at 07:08 AM02493-0.72%
Mabwell says China NMPA clears 9MW5211 vitiligo trial applicationPUBT·Jul 15 at 07:03 AM02493-0.72%688062-1.50%
Mabwell wins China NMPA IND clearance for LILRB4/CD3 bispecific 6MW5311 in blood cancersPUBT·Jun 23 at 07:00 PM688062-1.50%02493-0.72%
Mabwell reshapes senior leadership to bolster pharma growth and governanceTip Ranks·Jun 18 at 09:44 AM02493-0.72%
Mabwell Showcases Promising Nectin-4 ADC Data in Cervical Cancer at ESMO Gynae 2026Tip Ranks·Jun 18 at 09:43 AM688062-1.50%02493-0.72%
